Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17700
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aung, Ar Kar | - |
dc.contributor.author | Tang, Mei Jie | - |
dc.contributor.author | Adler, Nikki R | - |
dc.contributor.author | de Menezes, Sara Lee | - |
dc.contributor.author | Goh, Michelle Sue Yen | - |
dc.contributor.author | Tee, Hui Wen | - |
dc.contributor.author | Trubiano, Jason | - |
dc.contributor.author | Puy, Robert | - |
dc.contributor.author | Zubrinich, Celia Mary | - |
dc.contributor.author | Graudins, Linda Velta | - |
dc.date | 2018-05-07 | - |
dc.date.accessioned | 2018-05-08T23:56:56Z | - |
dc.date.available | 2018-05-08T23:56:56Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Journal of clinical pharmacology 2018; 58(10): 1332-1339 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/17700 | - |
dc.description.abstract | We describe adverse drug reaction (ADR) reporting characteristics and factors contributing to length of time to report by healthcare professionals. This is a retrospective study of voluntary reports to an Australian healthcare ADR Review Committee over a 2-year period (2015-2016). Descriptive and univariate models were used for outcomes, employing standardized ADR definitions. Hospital pharmacists reported 84.8% of the 555 ADRs: 70.3% were hospital onset reactions, and 71.7% were at least of moderate severity. Immunologically mediated reactions were most commonly reported (409, 73.7%). The median time to submit an ADR report was 3 (interquartile range 1-10) days. Longer median times to reporting were associated with multiple implicated agents and delayed hypersensitivity reactions, especially severe cutaneous adverse reactions. A total of 650 medications were implicated that involved multiple agents in 165/555 (29.7%) reports. Antimicrobials were the most commonly implicated agents. Immunologically mediated reactions were most commonly associated with antimicrobials and radiocontrast agents (P < .0001, odds ratio [OR] 3.6, 95%CI 2.4-5.5, and P = .04, OR 4.2, 95%CI 1.2-18.2, respectively). Opioids and psychoactive medications were more commonly implicated in nonimmunological reported ADRs (P = .0002, OR 3.9, 95%CI 1.9-7.9, and P < .0001, OR 11.4, 95%CI 4.6-27.8, respectively). Due to the predominant reporting of immunologically mediated reactions, a targeted education program is being planned to improve identification and accuracy of ADR reports, with the overall aim of improved management to ensure quality service provision and patient safety. | - |
dc.language.iso | eng | - |
dc.subject | Adverse drug reactions | - |
dc.subject | hypersensitivity | - |
dc.subject | medication safety | - |
dc.subject | pharmacoepidemiology | - |
dc.subject | pharmacovigilance | - |
dc.title | Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Journal of clinical pharmacology | - |
dc.identifier.affiliation | Monash University Malaysia, Johor Bahru, Malaysia | en |
dc.identifier.affiliation | Department of General Medicine, Alfred Health, Melbourne, Australia | - |
dc.identifier.affiliation | Department of Infectious Diseases, Alfred Health, Melbourne, Australia | - |
dc.identifier.affiliation | School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia | - |
dc.identifier.affiliation | Department of Dermatology, Alfred Health, Melbourne, Australia | - |
dc.identifier.affiliation | Department of Infectious Diseases, Austin Health, Melbourne, Australia | - |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Australia | - |
dc.identifier.affiliation | Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, Australia | - |
dc.identifier.affiliation | Pharmacy Department, Alfred Health, Melbourne, Australia | - |
dc.identifier.affiliation | Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia | - |
dc.identifier.doi | 10.1002/jcph.1148 | - |
dc.identifier.pubmedid | 29733431 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Trubiano, Jason | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Infectious Diseases | - |
crisitem.author.dept | Medicine (University of Melbourne) | - |
crisitem.author.dept | Centre for Antibiotic Allergy and Research | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.